PTX3 and neoplasm: In parallel with the inhibition of tumor-associated neovascularization, PTX3 overexpression resulted in a significant reduction in the recruitment of immune cell populations such as mast cells, macrophages, and T-lymphocytes (Figure 3, Figure 4, Figure 5 and Figure 6).